Demonstration of dapsone in urine and serum by ELISA inhibition.
作者信息
Huikeshoven H, Landheer J E, van Denderen A C, Vlasman M, Leiker D L, Das P K, Goldring O L, Pondman K W
出版信息
Lancet. 1978 Feb 4;1(8058):280-1. doi: 10.1016/s0140-6736(78)90533-0.
PMID:74707
Abstract
摘要
相似文献
1
Demonstration of dapsone in urine and serum by ELISA inhibition.
Lancet. 1978 Feb 4;1(8058):280-1. doi: 10.1016/s0140-6736(78)90533-0.
2
3
4
ELISA inhibition technique for the demonstration of sulphones in body fluids. The use of dried blood on filter paper to monitor leprosy patient compliance.
Lepr Rev. 1981 Sep;52(3):221-8. doi: 10.5935/0305-7518.19810032.
5
The effect of clofazimine on the pharmacokinetics of rifampicin and dapsone in leprosy.
J Antimicrob Chemother. 1986 Dec;18(6):715-8. doi: 10.1093/jac/18.6.715.
6
Dapsone metabolism in patients with dapsone-resistant leprosy.
Am J Trop Med Hyg. 1975 Nov;24(6 Pt 1):963-7. doi: 10.4269/ajtmh.1975.24.963.
7
Inhibition of dapsone excretion by probenecid.
Lancet. 1969 Oct 25;2(7626):884-5. doi: 10.1016/s0140-6736(69)92334-4.
8
Dapsone acetylation in man: another example of polymorphic acetylation.
Ann N Y Acad Sci. 1971 Jul 6;179:660-6. doi: 10.1111/j.1749-6632.1971.tb46942.x.
9
Armadillo as a model for studying chemotherapy of leprosy: preliminary studies.
Indian J Lepr. 1986 Jan-Mar;58(1):19-28.
10
Metabolic disposition of dapsone in African leprosy patients.
Lepr Rev. 1979 Mar;50(1):7-19. doi: 10.5935/0305-7518.19790002.
Zotero 插件